FitFlow Review
Best for: Annual-prepay shoppers wanting the lowest compounded GLP-1 price with board-certified telehealth care
FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro). Month-to-month pricing is $175/mo semaglutide and $235/mo tirzepatide, dropping to as low as $99 and $125/mo on annual prepay. A 4-step online process routes you to a board-certified provider, with US-licensed compounding pharmacies, free nationwide shipping, unlimited messaging, dose adjustments, FSA/HSA, and financing. Compounded meds are not FDA-approved; the pharmacy and state list are not published, and no LegitScript is shown.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
FitFlow is a solid telehealth option with balanced features and pricing.
FitFlow at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $175/mo (Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. Same active ingredient as Wegovy.)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored FitFlow
Each dimension is scored algorithmically from FitFlow’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.2/10At $175/mo, FitFlow runs in line with the $170 median for GLP-1 providers.
Effectiveness25%
8.8/10FitFlow offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.5/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-29).
Accessibility10%
7.2/10FitFlow's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
7.1/10Clinician messaging between visits.
How we verified this FitFlow review
Last checked 2026-06-29- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications FitFlow offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Month-to-month; drops to $145/mo (quarterly), $120/mo (6-month), or $99/mo on annual prepay. Same active ingredient as Wegovy.
Month-to-month; drops to $199/mo (quarterly), $175/mo (6-month), or $125/mo on annual prepay. Same active ingredient as Mounjaro.
Ready to get started?
Plans and promotions change often — check FitFlow's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
- 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
- Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
- FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
- Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)
Watch-outs
- Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
- Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
- State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
- No LegitScript certification displayed
Is FitFlow worth it? Our verdict
FitFlow positions itself around one thing: Annual-prepay shoppers wanting the lowest compounded GLP-1 price with board-certified telehealth care. It runs $175/month.
How much FitFlow actually costs
- Compounded semaglutide — $175/month
- Compounded tirzepatide — $235/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
Medications: what FitFlow prescribes
FitFlow prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who FitFlow is best for — and who should skip it
A good fit if you…
- value being able to message a clinician between visits.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
FitFlow offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
FitFlow is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
Ready to start with FitFlow?
Starting at $175/month. See current pricing and start your free consultation.
Alternatives to FitFlow
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this FitFlow review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with FitFlow?
Starting at $175/month. See current pricing and start your free consultation.